SC
WHWK

Steven Cohen’s Whitehawk Therapeutics WHWK Stock Holding History

Steven Cohen’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
57,129
+29,103
+104% +$121K ﹤0.01% 3421
2026
Q1 		$96.7K Buy
+28,026
New +$87.7K ﹤0.01% 3616
2023
Q2 		– Sell
-86
Closed -$623 – 2884
2023
Q1 		$623 Sell
86
-65,980
-100% -$705K ﹤0.01% 2134
2022
Q4 		$848K Sell
66,066
-501,063
-88% -$6.54M ﹤0.01% 1078
2022
Q3 		$8.01M Buy
567,129
+25,085
+5% +$330K 0.03% 575
2022
Q2 		$6.68M Buy
542,044
+330,513
+156% +$4.91M 0.03% 623
2022
Q1 		$3.59M Buy
+211,531
New +$4.05M 0.01% 770
2021
Q1 		– Sell
-16,667
Closed -$245K – 1216
2020
Q4 		$245K Buy
+16,667
New +$356K ﹤0.01% 865

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steven Cohen's WHWK Position: Q2 2026 in Review

Steven Cohen increased its Whitehawk Therapeutics (WHWK) stake by 104% in Q2 2026, buying an estimated $121K and bringing the position to 57,129 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Steven Cohen first reported a position in WHWK in Q4 2020 and has held it in 8 quarters since. The position peaked at $8.01M in Q3 2022. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Steven Cohen held 57,129 shares of Whitehawk Therapeutics worth $262K as of Q2 2026.
  • Steven Cohen bought 29,103 Whitehawk Therapeutics shares in Q2 2026, an estimated $121K.
  • Whitehawk Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3421 holding.
  • Steven Cohen first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • Steven Cohen's Whitehawk Therapeutics position peaked at $8.01M in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.